FDA grants Thermedx 510(k) clearance for optional fluid warming in arthroscopic, hysteroscopic procedures

Thermedx, LLC, an innovative designer and manufacturer of "smart" surgical irrigation products, received FDA 510(k) clearance for optional fluid warming in arthroscopic and hysteroscopic procedures. Building upon its prior FDA 510(k) clearance(s) for irrigation, distension, and deficit monitoring in gynecology, urology, and orthopedics, and optional fluid warming for urology, the fluid warming capabilities added to Thermedx's multi-functional Thermedx FluidSmart™ System provide hospitals and surgery centers with a single solution for surgical irrigation and optional warming within multiple disciplines.

"Our customers requested the expanded fluid warming capabilities added to our FluidSmart™ System for patient warming and other potential benefits. This clearance now allows for a unique comprehensive surgical irrigation system for gynecology hysteroscopic fluid management, urology irrigation in prostate, kidney stone, and bladder procedures, and in orthopedics for arthroscopy irrigation. Due to the clear visualization, pressure control, deficit monitoring, and optional fluid warming features, the FluidSmart™ System is becoming the preferred choice for an increasing number of hospitals and surgery centers," said Doug Carr, President & CEO of Thermedx. "We look forward to continued customer-driven innovation."

Thermedx is now the only company with FDA clearance to provide optional fluid warming, as part of its novel surgical irrigation system, specifically for gynecology and orthopedic endoscopic procedures.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Discovery of stem-like CD4 T cells offers new hope for cancer immunotherapy